ArticleCancer cell international2022

LINC00893 inhibits the progression of prostate cancer through miR-3173-5p/SOCS3/JAK2/STAT3 pathway.

Chuigong Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.